NATCO Pharma files draft letter of offer for up to Rs 1,300 crore rights issue

Corporate Actions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹825.75

prior close

₹825.55

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.0%-0.8% vs market

Pharmaceuticals peers, median of 172sector-0.6%-0.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.2

15m

-0.2

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8+0.0-0.8-0.6-0.3

Next day

-1.1-0.5-0.6-0.6-0.5

-1.2-2.9+1.8-1.9+0.8

-1.3-3.1+1.8-2.4+1.1

-0.8-2.3+1.5-1.5+0.7

-1.5-0.8-0.7-1.0-0.5

-1.3-0.9-0.3-0.4-0.9

15d

-0.5-4.2+3.8-3.4+3.0

-3.1-3.6+0.5-4.5+1.4

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NATCO Pharma has filed a Draft Letter of Offer with BSE and NSE for a proposed Rights Issue of equity shares. The issue size is up to Rs 1,300 crore with face value of Rs 2 per share. Issue price, entitlement ratio, and record date are yet to be finalized. Eligible shareholders on the record date will receive Rights Entitlements. KFin Technologies is the registrar and Kotak Mahindra Bank is the banker to the issue.

Likely market impact

Existing shareholders can subscribe to new shares in proportion to their holding on record date. They may need to invest extra capital or choose to let rights lapse.